The Opioid Use Disorder Market is expected to register a CAGR of 10.8% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Opioid Use Disorder Market report covers analysis by Drug Type (Buprenorphine, Methadone, Naltrexone), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Opioid Use Disorder Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Opioid Use Disorder Market Segmentation
Drug Type- Buprenorphine
- Methadone
- Naltrexone
Strategic Insights
Opioid Use Disorder Market Growth Drivers- Increasing Prevalence of Opioid Addiction: Opioid addiction has increased worldwide due to both prescription opioid misuse and the growing availability of illicit opioids, including heroin and synthetic opioids like fentanyl. The epidemic has driven a surge in demand for effective treatment options to manage withdrawal symptoms and reduce dependency, thereby driving market growth for OUD treatments.
- Government Initiatives and Regulatory Support: Governments of the world are now acknowledging the crisis of opioids to be a health emergency and initiating various measures such as financing treatment programs, regulatory changes for making medication-assisted treatment (MAT) more accessible to patients, and reducing the issuance of prescriptions related to opioids. All these developments are further fostering investment in the OUD treatment market.
- Development of new drugs: Pharmaceutical companies are now investing in new therapies. New developments include the long-acting release, non-opioid, and opioid-receptor therapies given through novel methods. These changes improve the treatments, bring new treatments for better patient care, challenge each other, and make the industry grow.
- Shift Towards Holistic and Comprehensive Treatment Models: There is an increasing recognition that OUD needs a multi-faceted treatment approach that incorporates pharmacological treatments with behavioral therapy and support systems. These holistic models address both the physical and psychological aspects of addiction, thereby improving overall treatment success rates and driving market demand for a variety of therapeutic options.
- Digital Therapeutics: Mobile applications and telehealth platforms are increasingly being used to provide remote support, track patient progress, and deliver therapy sessions. Such technologies promote more engagements and accessibility, which can now reach more unrepresented geographical areas, opening new avenues for growth in the OUD treatment market.
- Long-acting formulations: These will include long-acting injectables and implants. The advantages of these will be improved compliance, reduced risk of misuse, and sustained therapeutic effects. These will make long-acting formulations attractive to both patients and healthcare providers, accelerating their adoption as well as increasing market growth.
- Development of Non-Addictive Medications: There is a significant need for non-addictive medications regarding the treatment of pain and OUDs. Companies that continue to put more investment into the development of alternatives will eventually capture a huge market share due to the growing demand for safer options.
- Collaborations and Partnerships: Collaborations between pharmaceutical companies, healthcare providers, and the government will ensure that OUD solutions are holistic. It allows for innovation and increases accessibility to care, makes the regulatory approval process more streamlined, and can create mutual benefits and market growth.
- Advances in Genetics and Biomarkers: Understanding the genetic and biological factors that predispose individuals to OUD can lead to the development of targeted therapies and preventative measures. Research in this area presents opportunities for the creation of personalized treatments that can improve patient outcomes and expand the market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Opioid Use Disorder Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Opioid Use Disorder Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Opioid Use Disorder Market are Increasing Prevalence of Opioid Addiction, Government Initiatives and Regulatory Support, and Development of new drugs
The key future trends of the market are Shift Towards Holistic and Comprehensive Treatment Models, Digital Therapeutics, and Long-acting formulations
The leading players operating in the Opioid Use Disorder Market include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Opioid Use Disorder Market - By Drug Type
1.3.2 Opioid Use Disorder Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OPIOID USE DISORDER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OPIOID USE DISORDER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. OPIOID USE DISORDER MARKET - GLOBAL MARKET ANALYSIS
6.1. OPIOID USE DISORDER - GLOBAL MARKET OVERVIEW
6.2. OPIOID USE DISORDER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OPIOID USE DISORDER MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. BUPRENORPHINE
7.3.1. Overview
7.3.2. Buprenorphine Market Forecast and Analysis
7.3.3. Bunavail Market
7.3.3.1. Overview
7.3.3.2. Bunavail Market Forecast and Analysis
7.3.4. Sublocade Market
7.3.4.1. Overview
7.3.4.2. Sublocade Market Forecast and Analysis
7.3.5. Suboxone Market
7.3.5.1. Overview
7.3.5.2. Suboxone Market Forecast and Analysis
7.3.6. Zubsolv Market
7.3.6.1. Overview
7.3.6.2. Zubsolv Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. METHADONE
7.4.1. Overview
7.4.2. Methadone Market Forecast and Analysis
7.5. NALTREXONE
7.5.1. Overview
7.5.2. Naltrexone Market Forecast and Analysis
8. OPIOID USE DISORDER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Opioid Use Disorder Market Overview
8.1.2 North America Opioid Use Disorder Market Forecasts and Analysis
8.1.3 North America Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.1.4 North America Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.1.4.1 United States Opioid Use Disorder Market
8.1.4.1.1 United States Opioid Use Disorder Market by Drug Type
8.1.4.2 Canada Opioid Use Disorder Market
8.1.4.2.1 Canada Opioid Use Disorder Market by Drug Type
8.1.4.3 Mexico Opioid Use Disorder Market
8.1.4.3.1 Mexico Opioid Use Disorder Market by Drug Type
8.2. EUROPE
8.2.1 Europe Opioid Use Disorder Market Overview
8.2.2 Europe Opioid Use Disorder Market Forecasts and Analysis
8.2.3 Europe Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.2.4 Europe Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Opioid Use Disorder Market
8.2.4.1.1 Germany Opioid Use Disorder Market by Drug Type
8.2.4.2 France Opioid Use Disorder Market
8.2.4.2.1 France Opioid Use Disorder Market by Drug Type
8.2.4.3 Italy Opioid Use Disorder Market
8.2.4.3.1 Italy Opioid Use Disorder Market by Drug Type
8.2.4.4 Spain Opioid Use Disorder Market
8.2.4.4.1 Spain Opioid Use Disorder Market by Drug Type
8.2.4.5 United Kingdom Opioid Use Disorder Market
8.2.4.5.1 United Kingdom Opioid Use Disorder Market by Drug Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Opioid Use Disorder Market Overview
8.3.2 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis
8.3.3 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.3.4 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Opioid Use Disorder Market
8.3.4.1.1 Australia Opioid Use Disorder Market by Drug Type
8.3.4.2 China Opioid Use Disorder Market
8.3.4.2.1 China Opioid Use Disorder Market by Drug Type
8.3.4.3 India Opioid Use Disorder Market
8.3.4.3.1 India Opioid Use Disorder Market by Drug Type
8.3.4.4 Japan Opioid Use Disorder Market
8.3.4.4.1 Japan Opioid Use Disorder Market by Drug Type
8.3.4.5 South Korea Opioid Use Disorder Market
8.3.4.5.1 South Korea Opioid Use Disorder Market by Drug Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Opioid Use Disorder Market Overview
8.4.2 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis
8.4.3 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.4.4 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Opioid Use Disorder Market
8.4.4.1.1 South Africa Opioid Use Disorder Market by Drug Type
8.4.4.2 Saudi Arabia Opioid Use Disorder Market
8.4.4.2.1 Saudi Arabia Opioid Use Disorder Market by Drug Type
8.4.4.3 U.A.E Opioid Use Disorder Market
8.4.4.3.1 U.A.E Opioid Use Disorder Market by Drug Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Opioid Use Disorder Market Overview
8.5.2 South and Central America Opioid Use Disorder Market Forecasts and Analysis
8.5.3 South and Central America Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.5.4 South and Central America Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Opioid Use Disorder Market
8.5.4.1.1 Brazil Opioid Use Disorder Market by Drug Type
8.5.4.2 Argentina Opioid Use Disorder Market
8.5.4.2.1 Argentina Opioid Use Disorder Market by Drug Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. OPIOID USE DISORDER MARKET, KEY COMPANY PROFILES
10.1. INDIVIOR
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ALKERMES
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. TITAN PHARMACEUTICALS
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. HIKMA PHARMACEUTICALS
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. TEVA PHARMACEUTICALS
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. MEDICINOVA
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. OREXO
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. CAMURUS
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. OMEROS
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. AMYGALDA NEUROSCIENCES
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. Indivior2. Alkermes3. Titan Pharmaceuticals4. Hikma Pharmaceuticals5. Teva Pharmaceuticals6. MediciNova7. Orexo8. Camurus9. Omeros10. Amygalda Neurosciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.